Elad Gil, a prominent solo investor, is leading a $250 million funding round for Abridge, a Pittsburgh-based healthcare startup that utilizes artificial intelligence to transcribe doctor-patient conversations. This investment values Abridge at a pre-money valuation of $2.5 billion. The startup is generating $50 million in annual recurring revenue (ARR), reflecting a revenue multiple of 50x in this latest funding round. In addition to the funding, Abridge has announced a partnership with Wolters Kluwer to integrate UpToDate's trusted physician-authored content into its AI-generated clinical documentation, enhancing its service offerings in the medical field.